Michał Gil

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Small Cell Lung Cancer

Systematic Review

Epidermal Growth Factor Receptor

Top Venues

Annals of medicine

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Michał Gil, Magdalena Knetki-Wroblewska, Przemysław Niziński, Maciej Strzemski, Paweł Krawczyk
Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients. Annals of medicine 55 (1) (2023)
Izabela Chmielewska, Paweł Krawczyk, Anna Grenda, Magdalena Wójcik-Superczyńska, Natalia Krzyżanowska, Michał Gil, Janusz Milanowski
Breaking the 'Undruggable' Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations-A Comprehensive Review and Description of Single Site Experience. Cancers 15 (14) (2023)
Michał Gil, Magdalena Knetki-Wroblewska, Przemysław Niziński, Maciej Strzemski, Paweł Krawczyk
Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients. Annals of medicine 55 (1) (2023)
Kamila Wojas-Krawczyk, Paweł Krawczyk, Michał Gil, Maciej Strzemski
Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients-Mechanism of Action and Future Concepts. Cancers 13 (11) (2021)
Paweł Krawczyk, Anna Grenda, Paulina Terlecka, Justyna Błach, Kamila Wojas-Krawczyk, Tomasz Kucharczyk, Izabela Chmielewska, Robert Kieszko, Bożena Jarosz, Michał Gil, Katarzyna Reszka, Janusz Milanowski
Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement. Scientific reports 11 (1) (2021)